[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"menu":3,"$fhItbxoxXhwNMZIXcT1NwgloW8MQuRQLJ-nRGi8FNW_U":210},{"main":4,"mainTranslated":17,"footer":45,"footerTranslated":109},[5,8,11,14],{"title":6,"url":7},"Course library","https:\u002F\u002Fwww.medmastery.com\u002Fcourse-library",{"title":9,"url":10},"Pricing","https:\u002F\u002Fwww.medmastery.com\u002Fpricing",{"title":12,"url":13},"Earn credits","https:\u002F\u002Fwww.medmastery.com\u002Fcme-credits",{"title":15,"url":16},"Institutions","https:\u002F\u002Fwww.medmastery.com\u002Finstitutions",{"de":18,"es":27,"fr":36},[19,21,23,25],{"title":20,"url":7},"Kurse",{"title":22,"url":10},"Preise",{"title":24,"url":13},"CME-Punkte",{"title":26,"url":16},"Organisationen",[28,30,32,34],{"title":29,"url":7},"Biblioteca de cursos",{"title":31,"url":10},"Precios",{"title":33,"url":13},"Gana créditos",{"title":35,"url":16},"Instituciones",[37,39,41,43],{"title":38,"url":7},"Cours",{"title":40,"url":10},"Tarifs",{"title":42,"url":13},"Obtenir des crédits",{"title":44,"url":16},"Établissements",[46,59,79,97],{"title":47,"group":48,"menu":49},"Company",true,[50,53,56],{"title":51,"url":52},"Our teachers","https:\u002F\u002Fwww.medmastery.com\u002Fteachers",{"title":54,"url":55},"About us","https:\u002F\u002Fwww.medmastery.com\u002Fabout-us",{"title":57,"url":58},"Work with us","https:\u002F\u002Fwww.medmastery.com\u002Fwork-with-us",{"title":60,"group":48,"menu":61},"Product",[62,64,67,70,73,76,78],{"title":63,"url":7},"Courses",{"title":65,"url":66},"Magazine","https:\u002F\u002Fwww.medmastery.com\u002Fmagazine",{"title":68,"url":69},"Podcast","https:\u002F\u002Fwww.medmastery.com\u002Fpodcasts",{"title":71,"url":72},"Webinars","https:\u002F\u002Fwww.medmastery.com\u002Fwebinars",{"title":74,"url":75},"Guides","https:\u002F\u002Fwww.medmastery.com\u002Fguides",{"title":15,"url":77},"https:\u002F\u002Fwww.medmastery.com\u002Finstitutions\u002F",{"title":9,"url":10},{"title":80,"group":48,"menu":81},"Legal",[82,85,88,91,94],{"title":83,"url":84},"Imprint","https:\u002F\u002Fwww.medmastery.com\u002Fimprint",{"title":86,"url":87},"Newsletter policy","https:\u002F\u002Fwww.medmastery.com\u002Fnewsletter-privacy-policy",{"title":89,"url":90},"Privacy policy","https:\u002F\u002Fwww.medmastery.com\u002Fprivacy-policy",{"title":92,"url":93},"Cookie Policy","https:\u002F\u002Fwww.medmastery.com\u002Fcookie-policy",{"title":95,"url":96},"Terms","https:\u002F\u002Fwww.medmastery.com\u002Fterms",{"title":98,"group":48,"menu":99},"Customer support",[100,103,106],{"title":101,"url":102},"FAQs","https:\u002F\u002Fwww.medmastery.com\u002Ffaqs",{"title":104,"url":105},"Contact","https:\u002F\u002Fwww.medmastery.com\u002Fcontact",{"title":107,"url":108},"support@medmastery.com","mailto:support@medmastery.com",{"de":110,"es":143,"fr":177},[111,118,128,137],{"title":112,"group":48,"menu":113},"Unternehmen",[114,116,117],{"title":115,"url":52},"Unsere Dozentinnen und Dozenten",{"title":54,"url":55},{"title":57,"url":58},{"title":119,"group":48,"menu":120},"Produkt",[121,122,123,124,125,126,127],{"title":20,"url":7},{"title":65,"url":66},{"title":68,"url":69},{"title":71,"url":72},{"title":74,"url":75},{"title":26,"url":77},{"title":22,"url":10},{"title":129,"group":48,"menu":130},"Rechtliches",[131,133,134,135,136],{"title":132,"url":84},"Impressum",{"title":86,"url":87},{"title":89,"url":90},{"title":92,"url":93},{"title":95,"url":96},{"title":138,"group":48,"menu":139},"Kundenservice",[140,141,142],{"title":101,"url":102},{"title":104,"url":105},{"title":107,"url":108},[144,151,162,171],{"title":145,"group":48,"menu":146},"Empresa",[147,149,150],{"title":148,"url":52},"Nuestros profesores",{"title":54,"url":55},{"title":57,"url":58},{"title":152,"group":48,"menu":153},"Producto",[154,156,157,158,159,160,161],{"title":155,"url":7},"Cursos",{"title":65,"url":66},{"title":68,"url":69},{"title":71,"url":72},{"title":74,"url":75},{"title":35,"url":77},{"title":31,"url":10},{"title":163,"group":48,"menu":164},"Información legal",[165,167,168,169,170],{"title":166,"url":84},"Aviso legal",{"title":86,"url":87},{"title":89,"url":90},{"title":92,"url":93},{"title":95,"url":96},{"title":172,"group":48,"menu":173},"Atención al cliente",[174,175,176],{"title":101,"url":102},{"title":104,"url":105},{"title":107,"url":108},[178,185,196,204],{"title":179,"group":48,"menu":180},"Entreprise",[181,183,184],{"title":182,"url":52},"Nos enseignants",{"title":54,"url":55},{"title":57,"url":58},{"title":186,"group":48,"menu":187},"Produit",[188,189,190,191,192,193,194],{"title":38,"url":7},{"title":65,"url":66},{"title":68,"url":69},{"title":71,"url":72},{"title":74,"url":75},{"title":15,"url":77},{"title":195,"url":10},"Tarification",{"title":197,"group":48,"menu":198},"Mentions légales",[199,200,201,202,203],{"title":197,"url":84},{"title":86,"url":87},{"title":89,"url":90},{"title":92,"url":93},{"title":95,"url":96},{"title":205,"group":48,"menu":206},"Service client",[207,208,209],{"title":101,"url":102},{"title":104,"url":105},{"title":107,"url":108},{"content":211,"related":275,"meta":341,"internal":351},{"title":212,"leadIn":213,"category":214,"elements":217,"becomeAnExpert":239,"author":261,"readDuration":273,"readDurationFormatted":274},"Incidence and prevalence—what you really need to know","If you want to understand medical literature, you absolutely need to understand the difference between incidence and prevalence and what they have to do with one another.",{"id":215,"name":216},1,"Course previews",[218,229,234],{"type":219,"data":220},"video",{"readDurationInSeconds":221,"video":222},403,{"platform":223,"name":224,"url":225,"size":226},"YouTube","Incidence and prevalence - what you really need to know","https:\u002F\u002Fwww.youtube.com\u002Fwatch?v=XXJl2C1PxTQ",{"width":227,"height":228},200,113,{"type":230,"data":231},"free_text",{"readDurationInSeconds":232,"text":233},18.933333333333334,"\u003Cp>If you want to understand medical literature, you absolutely need to understand the difference between incidence and prevalence and what they have to do with one another. This video from our \u003Ca href=\"https:\u002F\u002Fwww.medmastery.com\u002Fcourse\u002Fepidemiology-essentials\">Epidemiology Essentials\u003C\u002Fa> course is ideal for anyone who’s just diving into clinical epidemiology. As you will learn, incidence is a measure of risk whereas prevalence is a measure of disease burden. Both parameters have their strengths and should be used in different settings.\u003C\u002Fp>\u003Cp>If you'd like to watch the rest of the course, sign up for a \u003Ca href=\"https:\u002F\u002Fwww.medmastery.com\u002Fuser\u002Fregister\">free trial account\u003C\u002Fa>!\u003C\u002Fp>",{"type":230,"data":235},{"readDurationInSeconds":236,"title":237,"text":238},210.66666666666666,"Video Transcript","\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:00:00] \u003C\u002Fb>Hey, everyone. This video is about incidence and prevalence. It's absolutely crucial to understand what incidence and prevalence are and what the difference between the two is. Incidence is a measure of disease risk, whereas prevalence measures disease burden. Incidence is defined as the number of new cases of a disease, during a specific time period, divided by the number of persons at risk for the disease, during that same time period. The resulting proportion can be \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:00:30] \u003C\u002Fb>multiplied by 1 000, in order to get the number of new cases per 1 000 population or by 100 in order to get the number of new cases per 100 population. That's up to the beholder. Let's take the example of a fictitious population of ten women free from disease, four of these women developed uterine cancer during a given year. So, the incidence is 4, divided by 10, times 1 000, equalling an incidence rate of 400 cases per 1 000 population per year. \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:01:00] \u003C\u002Fb>What's critical for incidence is that every person in the denominator must have the potential to become one of the people in the numerator. In fact, these four people are part of the denominator. They transition from disease-free to diseased. Incidence is a measure of events and therefore, a measure of risk. So, we said that everyone in the denominator must have the potential to become a member of the numerator or the disease group. Let's come back to our study of uterine cancer. \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:01:30]\u003C\u002Fb>If three women of our fictitious population had their uteruses removed, if they had undergone hysterectomy, in other words, they would no longer have the potential to become part of the numerator. So, instead of 4, divided by 10, it would now be 4, divided by 7, times 1 000, equals a new fictitious incidence rate of 570 per 1000. Now, what about prevalence? Prevalence is defined as the number of affected persons \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:02:00] \u003C\u002Fb>in the population, divided by the number of all persons in that population, at a specific point in time. So, in this fictitious example, it would be 3, divided by 10, times 1000, which would mean that we have a prevalence of 300 per 1000 population. And what's the difference between incidence and prevalence? Let's take a group of five people who developed tuberculosis over a period of six months. One develops the disease in January, two in February, one \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:02:30]\u003C\u002Fb> in April, and one in May. So, ignoring the denominator for now, the incident cases in February, for example, would be two. Or in other words, two would be the numerator of the incidence rate for that month and it would be one for the months of January, April, and May. Now, prevalence also takes into account the duration of the disease. Let's say case number one is cured in May, case number two is cured in April, case number three \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:03:00] \u003C\u002Fb>in March, case four and five during the second half of the year. Now, let's look at the prevalence of tuberculosis in these months. Let's also just focus on the numerator or the prevalent cases during each month. We have one case in January, three cases in February, three in March, three in April, three in May, and two in June. So, prevalence is determined by how many people joined the prevalence pool or the incidence and how many leave the prevalence pool, through death \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:03:30] \u003C\u002Fb>or cure. Let us depict that with a vessel full of pebbles. The vessel is filled with pebbles or new cases by the incidence rate and it's emptied by death or cure. This means that if death goes up then more people will leave the vessel, and if death goes down then more people will stay in the vessel and the same thing applies for cure. If more people are cured, more pebbles or people will leave the vessel. And cure rate goes down, then more pebbles \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:04:00] \u003C\u002Fb>or people will stay in the vessel. Let's have a closer look. Let's say this is our baseline prevalence. Now, what happens to prevalence if incidence goes up while death and cure stay the same? It has to go up, right? What happens if incidence stays the same but death goes down while cure rate stays the same? It will go up since fewer pebbles will leave the vessel. What if death goes down and cure rate goes up? Well, as you probably guessed correctly, prevalence will decrease since more pebbles will leave the vessel. \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:04:30] \u003C\u002Fb>So, prevalence is a measure of disease burden, as such, it is a great tool for planning the allocation of health services. So, prevalence is incidence, times duration. And duration is determined by the death rate or the cure rate. If the death rate or cure rate go up then the disease duration will be shortened. If death rate and cure rate go down, disease duration will be prolonged. At most points in time, prevalence will be lower, with shorter duration and higher, \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:05:00] \u003C\u002Fb>with longer duration of disease. Now, let's use another fictitious example to clarify this point. Let's use an example of coronary heart disease in two different populations. One is the population of Hollywood, the other one is the population of the Bronx. Our fictitious Hollywood has a prevalence of 50 cases per 1000 population. The Bronx, on the other hand, has a prevalence of 10 per 1000. So, to the person who's not familiar with the fact that prevalence is not a measure of \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:05:30] \u003C\u002Fb>risk but rather a measure of the burden of the disease. It looks like folks from Hollywood are at an increased risk of CHD but that conclusion is not true at all here. Let's look at the incidence rates, duration of disease in both locations. Incidence is 5 per 1000, per year, in both locations but duration of disease is 10 years in Hollywood, due to better care, whereas in the Bronx, people die from CHD after 2 years. So, in fact, the higher \u003C\u002Fp>\u003Cp dir=\"ltr\">\u003Cb id=\"docs-internal-guid-5026aed8-7fff-f198-af42-ffad906ec08a\">[00:06:00] \u003C\u002Fb>prevalence in Hollywood is just an expression of better care of an incurable disease. You see, we said prevalence is equal to incidence, times duration. So, 5 times 10 is 50, and 5 times 2 is 10. So, I hope the difference between incidence and prevalence is now crystal clear. Now, I would love to hear your thoughts in the comment section below.\u003C\u002Fp>",{"courses":240,"showAwardsBelow":48},[241],{"id":242,"isFreeCmeCourse":243,"title":244,"type":245,"specialization":246,"teachers":248,"cmeCredits":250,"teacherIllustration":251,"backgroundImage":252,"relativeUrl":253,"lastChanged":254,"created":255,"description":256,"relativeURL":253,"meta":257},3264,false,"Epidemiology Essentials","course",[247],"Professional development",[249],"Franz Wiesbauer, MD MPH",3,"https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F99f55efc-9690-424c-a061-fe3acd47ec8e","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F99f55efd-2f5d-4fc3-b4b3-4869f5041daf","\u002Fcourses\u002Fepidemiology-essentials","1768486227","1487078261","Do you want to be able to read and make sense of medical literature? This course provides a solid foundation in clinical epidemiology—one that you can build on with more advanced epidemiology in the future. We’ll teach you how to measure and express mortality, incidence, and prevalence, how to express prognosis, the essential basics of clinical trials, how to measure test validity, and more!",{"duration":258,"quizzes":259,"lessons":260},6678,6,30,{"id":262,"name":249,"image":263,"profession":264,"relativeUrl":267,"specializations":268},1563,"https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F9c43cef0-41ee-4005-9e4a-d8711c816401",{"name":265,"description":266},"Internist","Franz is the founder and CEO of Medmastery. He is an internist with a specialization in cardiology and a master’s in public health from Johns Hopkins University.","\u002Fteachers\u002Ffranz-wiesbauer-md-mph",[269,247,270,271,272],"Nephrology","Cardiology","Ultrasound","Emergency medicine and critical care",238,"4m",[276,298,317],{"id":277,"title":278,"text":279,"image":280,"author":288,"path":291,"readDuration":292,"readDurationFormatted":293,"internal":294},1350,"How to Recognize INOCA (ANOCA) on an Exercise Stress Test ","Angina, abnormal stress test, clean coronaries—that's INOCA (or ANOCA), and it carries real risk. Learn to recognize and report it with exercise stress ECG.",{"alt":281,"title":282,"size":283,"location":285},"Illustration of the heart's coronary vasculature showing large coronary arteries and the extensive network of smaller vessels affected in INOCA (ischemia with nonobstructive coronary arteries).","",{"width":284,"height":284},1200,{"bucket":286,"key":287},"public-drupal-medmastery-assets-production","\u002F2026-05\u002FC17(1)_magazine image_0.png",{"id":262,"title":249,"relativeURL":267,"image":263,"professionLong":266,"profession":289,"weight":290},{"name":265},4,"\u002Fmagazine\u002Fexercise-stress-ecg-inoca",141,"3m",{"created":295,"updated":296,"published":297},1778115738,1778118425,1778118255,{"id":299,"title":300,"text":301,"image":302,"author":308,"path":310,"readDuration":311,"readDurationFormatted":312,"internal":313},1348,"Hyperlipidemia screening: who, when, & what to measure","Testing for hyperlipidemia can help you mitigate your patients' cardiovascular risk. Learn who to screen and when, which measures to request, and how to stratify risk.",{"alt":303,"title":282,"size":304,"location":306},"Lipid panel blood sample tubes used to test for hyperlipidemia in a laboratory setting",{"width":305,"height":305},600,{"bucket":286,"key":307},"\u002F2026-04\u002FC121_magazine image.png",{"id":262,"title":249,"relativeURL":267,"image":263,"professionLong":266,"profession":309,"weight":290},{"name":265},"\u002Fmagazine\u002Ftest-for-hyperlipidemia",246,"5m",{"created":314,"updated":315,"published":316},1777403036,1777572381,1777412421,{"id":318,"title":319,"text":320,"image":321,"author":326,"path":335,"readDuration":336,"readDurationFormatted":274,"internal":337},1347,"Outpatient care for COPD exacerbations","Most acute COPD exacerbations can be managed with outpatient treatment. Learn how to treat mild and moderate COPD exacerbations—and when to escalate care.",{"alt":322,"title":282,"size":323,"location":324},"Older patient using a handheld nebulizer to inhale bronchodilator medication during an acute COPD exacerbation",{"width":305,"height":305},{"bucket":286,"key":325},"\u002F2026-04\u002FC133(4)_ exacerbations_magazine image.png",{"id":327,"title":328,"relativeURL":329,"image":330,"professionLong":331,"profession":332,"weight":334},5365,"Siamak Moayedi, MD","\u002Fteachers\u002Fsiamak-moayedi-md","https:\u002F\u002Fmedmastery-backend-prod-kjbeds.s3.eu-west-1.amazonaws.com\u002Fmedia\u002Fimages\u002F9c43cf02-1064-4074-817b-0eb5de6ded74","Professor and Director of Medical Student Education, University of Maryland and Course Director, Essential and Critical Procedures, Emergency Medicine.",{"name":333},"Emergency medicine physician",1533,"\u002Fmagazine\u002Facute-copd-exacerbation-treatment",191,{"created":338,"updated":339,"published":340},1776705362,1776710540,1776710541,{"seo":342,"og":344},{"title":343,"description":213},"Incidence and prevalence—what you really need to know | Medmastery",{"title":343,"description":213,"image":345},{"alt":282,"title":282,"size":346,"location":349},{"width":347,"height":348},480,261,{"bucket":286,"key":350},"\u002Fmigrated-images\u002Fmagazine_160724.png",{"id":352,"created":353,"updated":354,"published":353},88,1469352147,1736176778]